Free Trial

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down - What's Next?

Telix Pharmaceuticals Limited American Depositary Shares logo with Medical background
Remove Ads

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report)'s share price gapped down before the market opened on Tuesday . The stock had previously closed at $20.93, but opened at $19.84. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $20.32, with a volume of 40,699 shares.

Analysts Set New Price Targets

TLX has been the subject of a number of recent research reports. UBS Group lifted their price objective on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a "buy" rating in a research note on Monday, January 27th. William Blair upgraded Telix Pharmaceuticals Limited American Depositary Shares to a "strong-buy" rating in a research report on Tuesday, November 19th.

Check Out Our Latest Stock Report on TLX

Telix Pharmaceuticals Limited American Depositary Shares Trading Down 4.9 %

The company's fifty day moving average is $17.07.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

(Get Free Report)

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.

Read More

Should You Invest $1,000 in Telix Pharmaceuticals Limited American Depositary Shares Right Now?

Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.

While Telix Pharmaceuticals Limited American Depositary Shares currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Is There Still Money in AI? How to Invest in the Next Big Wave

Is There Still Money in AI? How to Invest in the Next Big Wave

The AI sector has taken a hit, but is the opportunity gone? Shah Gilani breaks down the current state of AI stocks and the next AI company with 10x potential.

Related Videos

Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
Elon Musk’s First 100 Days of DOGE: 3 AI Stocks Ready to Soar
7 Inflation-Proof Stocks to Protect Your Portfolio

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads